Pristiq (desvenlafaxine) is a prescription drug that’s used to treat major depressive disorder (MDD). This drug can interact with other medications and some supplements. For example, Pristiq can ...
SAN DIEGO, May 8 (Reuters) - Wyeth's experimental drug Pristiq alleviates symptoms of menopause such as hot flashes without a significant impact on sexual function, researchers said on Tuesday, but ...
Results from Phase 3 Efficacy Sub-study Presented at the 59 th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists PRISTIQ, which is approved by the U.S. Food and Drug ...
Wyeth Receives Approvable Letter From FDA For Pristiq For The Treatment Of Major Depressive Disorder MADISON, N.J., Jan. 23 -- Wyeth Pharmaceuticals, a division of Wyeth , announced today that the ...
An experimental treatment for menopause-related hot flashes and night sweats that doesn't use hormones generally works well, researchers report. The new medication, called Pristiq, is under review by ...
For the second time in recent months, Pfizer ($PFE) is having to recall hundreds of thousands of bottles of a drug when one was found to contain the wrong tablet ...
NEW YORK, Dec 12 (Reuters) - Wyeth said on Wednesday that a low-dose 50-milligram form of its experimental Pristiq depression drug was effective in two late-stage trials and far better tolerated than ...
The US Food and Drug Administration has told Wyeth that it must sort out quality control at one of its manufacturing plants if it is to receive approval for its new antidepressant Pristiq. The US Food ...
Wyeth has suffered a double-dose of bad news after the US drug major said it is pulling its European application for Pristiq to treat hot flushes, while a Phase III trial of the bowel drug ...
WASHINGTON The Food and Drug Administration recently approved the antidepressant drug Pristiq, manufactured by Wyeth. The approval sparked a bit of controversy, however, as Pristiq bears a striking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results